SPRY

SPRY Total Non-Current Liabilities

$176.12MQuarterly · USD

Period ending:

SPRY FY Total Non-Current LiabilitiesUSD
SPRY FY Total Non-Current Liabilities2018-12-31: $4.21M2019-12-31: $3.32M2020-12-31: $32.25M2021-12-31: $84.53M2022-12-31: $3.11M2023-12-31: $37.00K2024-12-31: $70.92M2025-12-31: $174.25M$174.25M$0.00
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

SPRY total non-current liabilities history

Long-term obligations due beyond one year. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Ars Pharmaceuticals Inc Total Non-Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Non-Current Liabilities (USD)
174,249,000
70,915,000
36,999
3,105,000
84,528,000
32,249,000
3,324,000
4,206,000

Compare total non-current liabilities

All SPRY financial metrics · SPRY stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.